Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProLOGUE: Brodalumab Treatment in Real-Life Plaque Psoriasis
jRCTs031180037Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of brodalumab in plaque psoriasis, sponsored by Kyowa Kirin. Started Nov 2017; status: completed.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCTs031180037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180037.